1. P401 Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications: Reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. (27th May 2021) Authors: Lamb, C A; Sebastian, S; Kent, A J; Segal, J P; Gonzalez, H A; Brookes, M J; Mehta, S J; Subramanian, S; Bhala, N; Hicks, L C; Conley, T E; Patel, K V; Walker, G J; Kennedy, N A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P482 Safety and efficacy of ustekinumab for Crohn's disease in the elderly population. (27th May 2021) Authors: Fiske, J; Liu, E; Limdi, J; Conley, T E; Townsend, T; Davies, M; Brockwell, R; Baig, D; Abdelbadiee, S; Uney, A; Liaros, A; Gaba, W; Smith, P J; Subramanian, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗